基本信息
浏览量:223

个人简介
Structural Biology and Translational Cancer Research
1. Structural Basis of Transmembrane Signaling
Our research is dedicated to uncovering the biochemical and structural intricacies of cross-membrane signaling, with a primary focus on 7-transmembrane G-protein-coupled receptors (GPCRs) and single-pass transmembrane receptors. In the realm of GPCRs, we strive to elucidate the activation mechanisms of both GPCRs and G-proteins, which are pivotal in biological signaling. To explore these molecular intricacies, we employ advanced cryo-electron microscopy (Cryo-EM) techniques. Our research also extends to investigating the structural basis of single-pass transmembrane receptors, aiming to provide a comprehensive understanding of transmembrane signaling processes.
2. Tumor Metastasis, Cancer Immunotherapy, and Drug Development
Tumor metastasis, the leading cause of cancer-related deaths, is a primary focus of our research. We delve into the mechanisms underlying tumor cell migration and invasion, identifying key proteins that drive these processes. By targeting these proteins for drug development, we aim to create effective treatments to curb tumor metastasis. Additionally, our research explores the roles of dendritic cells in cancer immunotherapy, contributing to the development of new cancer treatment approaches.
1. Structural Basis of Transmembrane Signaling
Our research is dedicated to uncovering the biochemical and structural intricacies of cross-membrane signaling, with a primary focus on 7-transmembrane G-protein-coupled receptors (GPCRs) and single-pass transmembrane receptors. In the realm of GPCRs, we strive to elucidate the activation mechanisms of both GPCRs and G-proteins, which are pivotal in biological signaling. To explore these molecular intricacies, we employ advanced cryo-electron microscopy (Cryo-EM) techniques. Our research also extends to investigating the structural basis of single-pass transmembrane receptors, aiming to provide a comprehensive understanding of transmembrane signaling processes.
2. Tumor Metastasis, Cancer Immunotherapy, and Drug Development
Tumor metastasis, the leading cause of cancer-related deaths, is a primary focus of our research. We delve into the mechanisms underlying tumor cell migration and invasion, identifying key proteins that drive these processes. By targeting these proteins for drug development, we aim to create effective treatments to curb tumor metastasis. Additionally, our research explores the roles of dendritic cells in cancer immunotherapy, contributing to the development of new cancer treatment approaches.
研究兴趣
论文共 154 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
The oncologist (2025)
Yilin Shen, Jichang Wu,Chenling Shen,Xinyun Huang,Cui Fan,Haixia Hu, Zenghui Cheng,Biao Li,Mingliang Xiang,Bin Ye
Diagnostics (Basel, Switzerland)no. 9 (2025)
Miao Zhang, Tangjia Cai,Shiwei Jin,Xinyun Huang, Yuting Gao, Xiaoyue Chen,Wanyan Ouyang,Yi Tao,Yuanfang Liu,Yan Wang,Hongping Meng,Jian Li,Xiaozhu Lin,Kuangyu Shi,Jin Wang,Xiaoyi Ding,Jian-Qing Mi,Biao Li
European journal of nuclear medicine and molecular imaging (2025)
Nan Wang,Xin-Yun Huang,Xu-Feng Jiang,Li Wang,Shu Cheng, Peng-Peng Xu,Lei Dong,Bin-Shen Ou-Yang,Rong-Ji Mu,Chen Li,Yan Zhao,Yan Feng, Hong-Jing Dou,Zhong Zheng,Wei-Li Zhao
HEMATOLOGICAL ONCOLOGYno. 1 (2025)
Signal Transduction and Targeted Therapyno. 1 (2024)
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2024)
Yue Wang, Xue Wang,Xinyun Huang,Ying Qian, Rongji Mu,Qing Shi,Di Fu,Hongmei Yi, Bin-Shen Ou-Yang, Zhuo Han Li,Shu Cheng,Wang Li, Ning Wen, Pengpeng Xu,Wei Li Zhao
Bloodno. Supplement 1 (2024): 6224-6224
加载更多
作者统计
#Papers: 154
#Citation: 11758
H-Index: 52
G-Index: 108
Sociability: 6
Diversity: 3
Activity: 45
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn